Quarterly report · Q2
8095.TEDINET S100OPJO
Period2021-12-01 → 2022-05-31
Filed2022-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.2bn | 2020-12-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2020-12-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥60.3bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥25.4bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.4bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.9bn | at 2021-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.9bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.6bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.06 | 2020-12-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.06 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.76 | 2020-12-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
| Reconciling Itemsreconciling | revenue | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | segment profit | 2020-12-01 → 2021-05-31 | −¥10m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥12.1bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥500m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥726m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥4m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2020-12-01 → 2021-05-31 | −¥350m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥36m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥206m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥6.5bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥102m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥923m |
| —segment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| —segment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| —segment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| —segment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 638
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 4060000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0996 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2051000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0503 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1720000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0421 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1377000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0338 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1188000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0291 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1044000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0256 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 970000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0237 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 670000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0164 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 666000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0163 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 658000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0161 | |
| Number of shares held | CurrentQuarterInstant | 14407000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3534 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 10800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 7300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 40678800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 406788 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 75466 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 40772366 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 406788 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 10800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 10800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0002 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row2Member | 7300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row2Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row2Member | 7300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row2Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 18100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 18100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0004 | |
| Number of male directors and other officers | CurrentQuarterInstant | 10 | |
| Number of female directors and other officers | CurrentQuarterInstant | 1 | |
| Ratio of female directors and other officers | CurrentQuarterInstant | 0.091 | |
| Cash and deposits | Prior1YearInstant | 10927061000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 10383126000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |